ARIUS Research Inc. · Toronto, ON Canada
| 55 York St., 15th Fl. | Phone: +1-416-862-2323 |
| Toronto, ON | Fax: +1-416-862-9696 |
| M5J 1R7 | |
| Canada | 
Map This Company |
ARIUS Research Inc. Rankings
Company Description
When it came to personalized cancer therapy, ARIUS Research put FunctionFIRST. The company's FunctionFIRST technology platform was created to discover potent antibodies for a range of cancer indications. ARIUS had assembled some 500 functional anti-cancer monoclonal antibodies (MAbs) for development. This variety addressed the unpredictable responses to existing drug therapies and allowed ARIUS to personalize treatments. Its most advanced products were being developed to treat breast, prostate, lung, ovarian, colorectal, and pancreatic cancers, as well as leukemia and melanoma. Business partners included
ARIUS Research Inc. Reports
No subscription, no problem.
Download presentation-ready reports. From company profiles to the competitive landscape, Hoover's offers immediate access to individual reports.
Financials
| Company Type | Subsidiary |
|---|---|
| Fiscal Year-End | December |
Executives
10 executives listed for ARIUS Research Inc.'s Toronto, ON location.
| Chairman, President, and Chief Science Officer | David Young | |
|---|---|---|
| CFO | Warren Whitehead | |
| VP | Helen Findlay |